Lubrano E, Spadaro A. Certolizumab: efficacy and safety profile of a novel pegylatedTNF-alpha blocking agent. Acta Biomed [Internet]. 2011 Sep. 1 [cited 2024 Jul. 27];82(1):26-34. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1362